Author

Kedar A. Patwardhan

AstraZeneca (United States)ORCID 0009-0002-2709-1339Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Organism:human· 1 Assay:imaging· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Harish RaviPrakashiD· 1 shared Ignacio Gonzalez-García· 1 shared Joachim Reischl· 1 shared José Domingo Salazar· 1 shared Paul Metcalfe· 1 shared Νικόλαος ΝικολάουiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Harish RaviPrakashORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BioinformaticsFrontiers in ImmunologyPeer-reviewedJun 10, 2024

Towards a Survival Risk Prediction Model for Metastatic NSCLC Patients on Durvalumab Using Whole-Lung CT Radiomics

Kedar A. Patwardhan, Harish RaviPrakash, Νικόλαος Νικολάου…·Joachim Reischl

This study develops machine learning models using CT radiomics and clinical data to predict survival in metastatic NSCLC patients on durvalumab, showing improved accuracy compared to PD-L1 status.

3 citations

𝕏 PostBluesky